MedTrace Logo

Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer

NCT06192030 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-01-05

No results posted yet for this study

Summary

The study aimed to develop and validate models to predict survival outcome and key mutations in patients with ovarian metastases of colorectal cancer, as well as to compare the differential gene expression between long-survival group and short-survival group.

Conditions

  • Ovarian Metastases of Colorectal Cancer

Interventions

OTHER

Prediction model

We develop and validate clinical models to predict patient survival and gene signatures in ovarian metastases of colorectal cancer.

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-27
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06192030 on ClinicalTrials.gov